Journal
MOLECULAR METABOLISM
Volume 14, Issue -, Pages 108-120Publisher
ELSEVIER
DOI: 10.1016/j.molmet.2018.05.019
Keywords
beta cell; Ca2+ signaling; Diabetes; Differentiation
Categories
Funding
- Swedish Research Council
- Hjarnfonden
- Novo Nordisk Foundation
- European Research Council [2015-AdG-695,136]
- Medical University of Vienna
Ask authors/readers for more resources
Objective: Specification of endocrine cell lineages in the developing pancreas relies on extrinsic signals from non-pancreatic tissues, which initiate a cell-autonomous sequence of transcription factor activation and repression switches. The steps in this pathway share reliance on activity-dependent Ca2+ signals. However, the mechanisms by which phasic Ca2+ surges become converted into a dynamic, cell-state-specific and physiologically meaningful code made up by transcription factors constellations remain essentially unknown. Methods: We used high-resolution histochemistry to explore the coincident expression of secretagogin and transcription factors driving beta cell differentiation. Secretagogin promoter activity was tested in response to genetically manipulating Pax6 and Pax4 expression. Secretagogin null mice were produced with their pancreatic islets morphologically and functionally characterized during fetal development. A proteomic approach was utilized to identify the Ca2+-dependent interaction of secretagogin with subunits of the 26S proteasome and verified in vitro by focusing on Pdx1 retention. Results: Here, we show that secretagogin, a Ca2+ sensor protein that controls alpha and beta cell turnover in adult, is in fact expressed in endocrine pancreas from the inception of lineage segregation in a Pax4-and Pax6-dependent fashion. By genetically and pharmacologically manipulating secretagogin expression and interactome engagement in vitro, we find secretagogin to gate excitation-driven Ca2+ signals for beta cell differentiation and insulin production. Accordingly, secretagogin(-/-) fetuses retain a non-committed pool of endocrine progenitors that co-express both insulin and glucagon. We identify the Ca2+-dependent interaction of secretagogin with subunits of the 26S proteasome complex to prevent Pdx1 degradation through proteasome inactivation. This coincides with retained Nkx6.1, Pax4 and insulin transcription in prospective b cells. Conclusions: In sum, secretagogin scales the temporal availability of a Ca2+-dependent transcription factor network to define beta cell identity. (C) 2018 The Authors. Published by Elsevier GmbH.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available